Clinuvel Pharmaceuticals Ltd (CUV.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CUV.AX | ||||
| Company | Clinuvel Pharmaceuticals Ltd | ||||
| Price Information | |||||
| Exchange | ASX | ||||
| Open | 12.250 | ||||
| High | 13.000 | ||||
| Low | 12.250 | ||||
| Latest | 12.750 | ||||
| Change | +0.520 | ||||
| % Change | +4.25% | ||||
| Volume | 163,129 | ||||
| 20-Day Average Volume | 82,257 | ||||
| Previous Close | 12.230 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 12.637 | ||||
| 20-Day Raw Stochastic | 51.33% | ||||
| 20-Day Relative Strength | 54.60 | ||||
| Weighted Alpha | +12.35 | ||||
| Today's Opinion | 100% Buy | ||||
| Previous Opinion | 88% Buy | ||||
| Last Month's Opinion | 88% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.87% since 01/08/26 | ||||
| Low | 12.080 on 01/14/26 | ||||
| High | 13.480 on 01/12/26 | ||||
| 1-Month | |||||
| %Chg | unch since 12/15/25 | ||||
| Low | 11.980 on 01/07/26 | ||||
| High | 13.480 on 01/12/26 | ||||
| 3-Month | |||||
| %Chg | +7.96% since 10/15/25 | ||||
| Low | 10.730 on 11/21/25 | ||||
| High | 13.480 on 01/12/26 | ||||
| 6-Month | |||||
| %Chg | +18.38% since 07/15/25 | ||||
| Low | 10.270 on 09/03/25 | ||||
| High | 14.000 on 08/27/25 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 613,955 | ||||
| Shares Outstanding, K | 50,201 | ||||
| Annual Sales | 95,017,570 | ||||
| Annual Net Income | 36,172,518 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | 0.050 on 09/04/25 | ||||
| Next Ex-Dividends Date | 09/04/25 | ||||
| Ratios | |||||
| Price/Earnings ttm | 17.03 | ||||